Fundraising FoxZafer Therapeutics
1 known investors
Find your way into Zafer Therapeutics
Sign up to see every warm intro you have to Zafer Therapeutics
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Zafer Therapeutics team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Zafer Therapeutics develops an allogeneic, off-the-shelf cell therapy platform that programs naive mesenchymal stromal cells (MSCs) in disease-mimicking environments to create targeted anti-inflammatory treatments for systemic autoimmune rheumatic diseases. Its lead candidate, HXB-319, is aimed initially at ANCA-associated vasculitis.
Founders & leadership
HB
Hulya BukulmezScientific & Clinical Collaborations (MD)
Investors · 1
Frequently asked questions
- What does Zafer Therapeutics do?
- Zafer Therapeutics develops an allogeneic, off-the-shelf cell therapy platform that programs naive mesenchymal stromal cells (MSCs) in disease-mimicking environments to create targeted anti-inflammatory treatments for systemic autoimmune rheumatic diseases. Its lead candidate, HXB-319, is aimed initially at ANCA-associated vasculitis.
- Who are Zafer Therapeutics's investors?
- Zafer Therapeutics's investors include CWRU Technology Ventures.